-
2
-
-
0031066347
-
Chemotherapy for adult soft tissue sarcoma: Does it work?
-
Saeter G: Chemotherapy for adult soft tissue sarcoma: does it work? Acta Orthop Scand 273: 139-144, 1997.
-
(1997)
Acta Orthop Scand
, vol.273
, pp. 139-144
-
-
Saeter, G.1
-
3
-
-
0026521884
-
Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult soft tissue sarcomas
-
Toma S, Palumbo R, Sogno G, Venturino A, Santi L: Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult soft tissue sarcomas. Ann Oncol 3 (Suppl. 2): 119-123, 1992.
-
(1992)
Ann Oncol
, vol.3
, Issue.2 SUPPL.
, pp. 119-123
-
-
Toma, S.1
Palumbo, R.2
Sogno, G.3
Venturino, A.4
Santi, L.5
-
4
-
-
0027518662
-
Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas
-
Toma S, Palumbo R, Canavese G, Albanese E, Cantoni E, Barisone A, Reggiardo G, Rosso R, Santi L: Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas. Cancer Chemother Pharmacol 31 (Suppl. 2): 222-227, 1993.
-
(1993)
Cancer Chemother Pharmacol
, vol.31
, Issue.2 SUPPL.
, pp. 222-227
-
-
Toma, S.1
Palumbo, R.2
Canavese, G.3
Albanese, E.4
Cantoni, E.5
Barisone, A.6
Reggiardo, G.7
Rosso, R.8
Santi, L.9
-
5
-
-
0027404526
-
Perspectives on anthracyclines plus ifosfamide in advanced soft tissue sarcomas
-
Casali P, Pastorino U, Azzarelli A, Bertulli R, Zucchinelli P, Devizzi L, Santoro A: Perspectives on anthracyclines plus ifosfamide in advanced soft tissue sarcomas. Cancer Chemother Pharmacol 31 (Suppl. 2): 228-232, 1993.
-
(1993)
Cancer Chemother Pharmacol
, vol.31
, Issue.2 SUPPL.
, pp. 228-232
-
-
Casali, P.1
Pastorino, U.2
Azzarelli, A.3
Bertulli, R.4
Zucchinelli, P.5
Devizzi, L.6
Santoro, A.7
-
6
-
-
0029164860
-
Results of single agents and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic
-
Sarcomas
-
Demetri GD, Elias AD: Results of single agents and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic. Sarcomas, Pt. II. Hematol Oncol Clin North Am 9: 765-785, 1995.
-
(1995)
Hematol Oncol Clin North Am
, vol.9
, Issue.2 PART
, pp. 765-785
-
-
Demetri, G.D.1
Elias, A.D.2
-
7
-
-
0030885437
-
A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced Soft tissue sarcomas
-
Bokemeyer C, Franzke A, Hartmann J, Schober C, Arseniev L, Metzner B, Link H, Kanz L, Schmoll HJ: A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced Soft tissue sarcomas. Cancer 80: 1221-1227, 1997.
-
(1997)
Cancer
, vol.80
, pp. 1221-1227
-
-
Bokemeyer, C.1
Franzke, A.2
Hartmann, J.3
Schober, C.4
Arseniev, L.5
Metzner, B.6
Link, H.7
Kanz, L.8
Schmoll, H.J.9
-
8
-
-
0030957418
-
Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced Soft Tissue Sarcomas: A pilot study
-
Frustaci S, Buonadonna A, Galligioni E, Favaro D, De Paoli A, Lo Re G, Sorio R, Tumolo S, Monfardini S: Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced Soft Tissue Sarcomas: a pilot study. J Clin Oncol 15: 1418-1426, 1997.
-
(1997)
J Clin Oncol
, vol.15
, pp. 1418-1426
-
-
Frustaci, S.1
Buonadonna, A.2
Galligioni, E.3
Favaro, D.4
De Paoli, A.5
Lo Re, G.6
Sorio, R.7
Tumolo, S.8
Monfardini, S.9
-
9
-
-
0344110204
-
Dose-intensive chemotherapy with Ifosfamide, Epirubicin, and filgastrim for adult patients with metastatic or locally advanced Soft Tissue Sarcoma: A phase II study
-
Reichardt P, Tilgner J, Hohenberger P, Dorken B: Dose-intensive chemotherapy with Ifosfamide, Epirubicin, and filgastrim for adult patients with metastatic or locally advanced Soft Tissue Sarcoma: a phase II study. J Clin Oncol 16: 1438-1443, 1998.
-
(1998)
J Clin Oncol
, vol.16
, pp. 1438-1443
-
-
Reichardt, P.1
Tilgner, J.2
Hohenberger, P.3
Dorken, B.4
-
10
-
-
0031687359
-
Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas
-
Leyvraz S, Bacchi M, Cerny T, Lissoni A, Sessa C, Bressoud A, Hermann R: Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Ann Oncol 9: 877-884, 1998.
-
(1998)
Ann Oncol
, vol.9
, pp. 877-884
-
-
Leyvraz, S.1
Bacchi, M.2
Cerny, T.3
Lissoni, A.4
Sessa, C.5
Bressoud, A.6
Hermann, R.7
-
11
-
-
0033036527
-
Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft Tissue Sarcomas: A phase II study
-
Palumbo R, Neumaier C, Cosso M, Bertero G, Raffo P, Spadini N, Valente S, Villani G, Pastorino M, Toma S: Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft Tissue Sarcomas: a phase II study. Eur J Cancer 35: 66-72, 1999.
-
(1999)
Eur J Cancer
, vol.35
, pp. 66-72
-
-
Palumbo, R.1
Neumaier, C.2
Cosso, M.3
Bertero, G.4
Raffo, P.5
Spadini, N.6
Valente, S.7
Villani, G.8
Pastorino, M.9
Toma, S.10
-
12
-
-
0027256397
-
Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin and cisplatin against advanced soft tissue sarcomas
-
Edmonson JK, Ryan LM, Blum RH, Brooks JS, Shiraki M, Grytak S, Parkinson DR: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 11: 1269-1275, 1993.
-
(1993)
J Clin Oncol
, vol.11
, pp. 1269-1275
-
-
Edmonson, J.K.1
Ryan, L.M.2
Blum, R.H.3
Brooks, J.S.4
Shiraki, M.5
Grytak, S.6
Parkinson, D.R.7
-
13
-
-
0029061785
-
Needed: Qualitative improvement in antisarcoma therapy
-
Edmonson JH: Needed: qualitative improvement in antisarcoma therapy. J Clin Oncol 13: 1531-1533, 1997.
-
(1997)
J Clin Oncol
, vol.13
, pp. 1531-1533
-
-
Edmonson, J.H.1
-
14
-
-
0029005580
-
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced Soft Tissue Sarcomas: A randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
-
Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, Buesa J, Casali P, Spooner D, Rankin E, Kirkpatrick A, Van Glabbeke M, van Oosterom: Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced Soft Tissue Sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 13: 1537-1545, 1995.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1537-1545
-
-
Santoro, A.1
Tursz, T.2
Mouridsen, H.3
Verweij, J.4
Steward, W.5
Somers, R.6
Buesa, J.7
Casali, P.8
Spooner, D.9
Rankin, E.10
Kirkpatrick, A.11
Van Glabbeke, M.12
Van Oosterom13
-
15
-
-
0028875404
-
Soft tissue sarcoma - Messages from completed randomsied trials
-
Gortzak E, van Coevorden F: Soft tissue sarcoma - Messages from completed randomsied trials. Eur J Surg Oncol 21: 469-477, 1995.
-
(1995)
Eur J Surg Oncol
, vol.21
, pp. 469-477
-
-
Gortzak, E.1
Van Coevorden, F.2
-
16
-
-
0023176119
-
Randomized comparison of three Adriamycin regimens for metastatic soft tissue sarcomas
-
Borden EC, Amato DA, Rosenbaum C, Enterline HT, Shiraki MJ, Creech RH, Lerner HJ, Carbone PP: Randomized comparison of three Adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol 5: 840-850, 1987.
-
(1987)
J Clin Oncol
, vol.5
, pp. 840-850
-
-
Borden, E.C.1
Amato, D.A.2
Rosenbaum, C.3
Enterline, H.T.4
Shiraki, M.J.5
Creech, R.H.6
Lerner, H.J.7
Carbone, P.P.8
-
17
-
-
0017704418
-
Dose response evaluation of Adriamycin in human neoplasia
-
O'Bryan RM, Baker LH, Gottlieb JE, Rivkin SE, Balcerzack SP, Grumet GN, Salmon SE, Moon TE, Hoogstraten B: Dose response evaluation of Adriamycin in human neoplasia. Cancer 39: 1940-1948, 1977.
-
(1977)
Cancer
, vol.39
, pp. 1940-1948
-
-
O'Bryan, R.M.1
Baker, L.H.2
Gottlieb, J.E.3
Rivkin, S.E.4
Balcerzack, S.P.5
Grumet, G.N.6
Salmon, S.E.7
Moon, T.E.8
Hoogstraten, B.9
-
18
-
-
0021173596
-
CYVADIC in advanced soft-tissue sarcoma - A randomized study comparing two schedules
-
A study of the EORTC Soft-Tissue and Bone Sarcoma Group
-
Pinedo HM, Bramwell VH, Mouridsen HT, Somers R, Vendrik CP, Santoro A, Buesa J, Vagener T, van Oosterom AT, van Unnik JA: CYVADIC in advanced soft-tissue sarcoma - A randomized study comparing two schedules. A study of the EORTC Soft-Tissue and Bone Sarcoma Group. Cancer 53: 1825-1832, 1984.
-
(1984)
Cancer
, vol.53
, pp. 1825-1832
-
-
Pinedo, H.M.1
Bramwell, V.H.2
Mouridsen, H.T.3
Somers, R.4
Vendrik, C.P.5
Santoro, A.6
Buesa, J.7
Vagener, T.8
Van Oosterom, A.T.9
Van Unnik, J.A.10
-
19
-
-
0027465117
-
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcoma: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
-
Steward WP, Verweij J, Somers R, Spooner D, Kerbrat O, Clavel M, Crowther D, Rousse J, Tursz T, Tueni E: Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcoma: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 11: 15-21, 1993.
-
(1993)
J Clin Oncol
, vol.11
, pp. 15-21
-
-
Steward, W.P.1
Verweij, J.2
Somers, R.3
Spooner, D.4
Kerbrat, O.5
Clavel, M.6
Crowther, D.7
Rousse, J.8
Tursz, T.9
Tueni, E.10
-
20
-
-
0020467212
-
Liposomes as in vivo carriers of adriamycin: Reduced cardiac uptake and preserved antitumor activity in mice
-
Gabizon A, Dagan A, Goren D, Barenholz Y, Fuks Z: Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res 42: 4734-4739, 1982.
-
(1982)
Cancer Res
, vol.42
, pp. 4734-4739
-
-
Gabizon, A.1
Dagan, A.2
Goren, D.3
Barenholz, Y.4
Fuks, Z.5
-
21
-
-
0018852428
-
Liposomal protection of adriamycin-induced cardiotoxicity in mice
-
Rahman A, Kessler A, More N, Sikic B, Rowden G, Woolley P, Schein PS: Liposomal protection of adriamycin-induced cardiotoxicity in mice. Cancer Res 40: 1532-1537, 1980.
-
(1980)
Cancer Res
, vol.40
, pp. 1532-1537
-
-
Rahman, A.1
Kessler, A.2
More, N.3
Sikic, B.4
Rowden, G.5
Woolley, P.6
Schein, P.S.7
-
22
-
-
0343084496
-
Dose escalation of liposome-encapsulated doxorubicin (D-99) with granulocyte colony stimulating factor (G-CSF) support in patients with advanced malignancies
-
abstract
-
O'Days SJ, Mazanet R, Skarin AT, Salgia R, Gordon D, Elias AD: Dose escalation of liposome-encapsulated doxorubicin (D-99) with granulocyte colony stimulating factor (G-CSF) support in patients with advanced malignancies. Proc Am Soc Clin Oncol 13: 153, 1994 (abstract).
-
(1994)
Proc Am Soc Clin Oncol
, vol.13
, pp. 153
-
-
O'Days, S.J.1
Mazanet, R.2
Skarin, A.T.3
Salgia, R.4
Gordon, D.5
Elias, A.D.6
-
23
-
-
0343084497
-
Early results of a phase II study of liposomal doxorubicin (Doxil) in refractory sarcoma
-
abstract
-
Skubitz KM: Early results of a phase II study of liposomal doxorubicin (Doxil) in refractory sarcoma. Proc Am Soc Clin Oncol 16: 508, 1997 (abstract).
-
(1997)
Proc Am Soc Clin Oncol
, vol.16
, pp. 508
-
-
Skubitz, K.M.1
-
24
-
-
0030994523
-
Phase I trial of dose-intense liposome-encapsulated doxorubicin in patients with advanced sarcoma
-
Casper ES, Schwartz GK, Sugarman A, Leung D, Brennan MF: Phase I trial of dose-intense liposome-encapsulated doxorubicin in patients with advanced sarcoma. J Clin Oncol 15: 2111-2117, 1997.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2111-2117
-
-
Casper, E.S.1
Schwartz, G.K.2
Sugarman, A.3
Leung, D.4
Brennan, M.F.5
-
25
-
-
0003219453
-
Phase II trial of doxil in advanced soft tissue sarcomas (STS)
-
Elson P, Chidiac T, Budd GT, Pelley R, Sandstrom K, McLain D, Crownover R, Marks K, Muschler C, Zher R, Joyce M, Bukowski R: Phase II trial of doxil in advanced soft tissue sarcomas (STS) (abstract). Proc Am Soc Clin Oncol 17: 513, 1998 (abstract).
-
(1998)
Proc Am Soc Clin Oncol
, vol.17
, pp. 513
-
-
Elson, P.1
Chidiac, T.2
Budd, G.T.3
Pelley, R.4
Sandstrom, K.5
McLain, D.6
Crownover, R.7
Marks, K.8
Muschler, C.9
Zher, R.10
Joyce, M.11
Bukowski, R.12
-
26
-
-
0031795043
-
A phase II study of Doxil (liposomal doxorubicin): Lack of activity in poor prognosis soft tissue sarcomas
-
Garcia AA, Kempf RA, Rogers M, Muggia FM: A phase II study of Doxil (liposomal doxorubicin): lack of activity in poor prognosis soft tissue sarcomas. Ann Oncol 9: 1131-1133, 1998.
-
(1998)
Ann Oncol
, vol.9
, pp. 1131-1133
-
-
Garcia, A.A.1
Kempf, R.A.2
Rogers, M.3
Muggia, F.M.4
-
27
-
-
0003486931
-
-
WHO Offset Publication No 48. Geneva, Switzerland, WHO
-
World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No 48. Geneva, Switzerland, WHO, 1979.
-
(1979)
WHO Handbook for Reporting Results of Cancer Treatment
-
-
-
28
-
-
0019365237
-
Reporting results of cancer treatment
-
Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47: 207-214, 1981.
-
(1981)
Cancer
, vol.47
, pp. 207-214
-
-
Miller, A.B.1
Hoogstraten, B.2
Staquet, M.3
Winkler, A.4
-
29
-
-
0005755484
-
Liposomal doxorubicin (Caelyx) in advanced pretreated Soft Tissue Sarcomas (STS): A phase II trial of the Italian Sarcoma Group (ISG)
-
abstract
-
Toma S, Tucci A, Villani G, Carteni G, Palumbo R: Liposomal doxorubicin (Caelyx) in advanced pretreated Soft Tissue Sarcomas (STS): a phase II trial of the Italian Sarcoma Group (ISG). Proc Am Soc Clin Oncol 18: 540, 1999 (abstract).
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
, pp. 540
-
-
Toma, S.1
Tucci, A.2
Villani, G.3
Carteni, G.4
Palumbo, R.5
-
30
-
-
0004845305
-
A randomized phase II trial of Caelyx/Doxil versus doxorubicin in advanced or metastatic Soft Tissue Sarcomas (STS)-An EORTC Soft Tissue and Bone Sarcoma Group (STBSG) trial
-
abstract
-
Judson I, Radford J, Blay JY, van Hoesel Q, Le Cesne A, van Oosterom A, Nielsen OS, Kamhy C, Woll P, Harris M, Hermans C, Donato di Paola E, Verweij J: A randomized phase II trial of Caelyx/Doxil versus doxorubicin in advanced or metastatic Soft Tissue Sarcomas (STS)-An EORTC Soft Tissue and Bone Sarcoma Group (STBSG) trial. Proc Am Soc Clin Oncol 18: 541, 1999 (abstract).
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
, pp. 541
-
-
Judson, I.1
Radford, J.2
Blay, J.Y.3
Van Hoesel, Q.4
Le Cesne, A.5
Van Oosterom, A.6
Nielsen, O.S.7
Kamhy, C.8
Woll, P.9
Harris, M.10
Hermans, C.11
Donato Di Paola, E.12
Verweij, J.13
-
31
-
-
0013170748
-
A phase II trial of Pegylated Liposomal Doxorubicin (Doxil) demonstrates activity in refractory sarcoma, mesothelioma, and head and neck cancer
-
abstract
-
Skubitz KM: A phase II trial of Pegylated Liposomal Doxorubicin (Doxil) demonstrates activity in refractory sarcoma, mesothelioma, and head and neck cancer. Proc Am Soc Clin Oncol 18: 541, 1999 (abstract).
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
, pp. 541
-
-
Skubitz, K.M.1
-
32
-
-
0030824158
-
Should high-dose chemotherapy be used in the treatment of Soft Tissue Sarcoma?
-
Reichardt P, Verweij J, Crowther D: Should high-dose chemotherapy be used in the treatment of Soft Tissue Sarcoma? Eur J Cancer 33: 1351-1360, 1997.
-
(1997)
Eur J Cancer
, vol.33
, pp. 1351-1360
-
-
Reichardt, P.1
Verweij, J.2
Crowther, D.3
-
33
-
-
0031925278
-
High-dose therapy for adult Soft Tissue Sarcomas: Dose response and survival
-
Elias AD: High-dose therapy for adult Soft Tissue Sarcomas: dose response and survival. Semin Oncol 25: 19-23, 1998.
-
(1998)
Semin Oncol
, vol.25
, pp. 19-23
-
-
Elias, A.D.1
-
34
-
-
9044237699
-
Prognostic factors in adult patients with locally controlled Soft Tissue Sarcoma: A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group
-
Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V, Mandard AM, Vilian MO, Jacquemier J, Duplay H, Sastre X, Barlier C, Henry-Amar M, Macß-Lesech J, Contesso G: Prognostic factors in adult patients with locally controlled Soft Tissue Sarcoma: a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 14: 869-877, 1946.
-
(1946)
J Clin Oncol
, vol.14
, pp. 869-877
-
-
Coindre, J.M.1
Terrier, P.2
Bui, N.B.3
Bonichon, F.4
Collin, F.5
Le Doussal, V.6
Mandard, A.M.7
Vilian, M.O.8
Jacquemier, J.9
Duplay, H.10
Sastre, X.11
Barlier, C.12
Henry-Amar, M.13
Macß-Lesech, J.14
Contesso, G.15
-
35
-
-
0032952928
-
Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcomas: An analysis of 2,185 patients treated with anthracycline-containing first-line regimens - A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study
-
Van Glabbeke M, van Oosterom AT, Oosterhuis JW, Mouridsen H, Crowther D, Somers R, Verweij J, Santoro A, Buesa J, Turs T: Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcomas: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens - A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study. J Clin Oncol 17: 150-157, 1999.
-
(1999)
J Clin Oncol
, vol.17
, pp. 150-157
-
-
Van Glabbeke, M.1
Van Oosterom, A.T.2
Oosterhuis, J.W.3
Mouridsen, H.4
Crowther, D.5
Somers, R.6
Verweij, J.7
Santoro, A.8
Buesa, J.9
Turs, T.10
-
36
-
-
17744412224
-
The outcome of advanced Soft Tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery
-
The Scandinavian Sarcoma Group Experience
-
Wiklund T, Saeter G, Strander H, Alvegard T, Blomqvist C: The outcome of advanced Soft Tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery. The Scandinavian Sarcoma Group Experience. Eur J Cancer 33: 357-361, 1997.
-
(1997)
Eur J Cancer
, vol.33
, pp. 357-361
-
-
Wiklund, T.1
Saeter, G.2
Strander, H.3
Alvegard, T.4
Blomqvist, C.5
|